User login
Key clinical point: Adherence to a Mediterranean diet before being diagnosed with breast cancer (BC) may improve survival outcomes, particularly in postmenopausal women.
Major finding: A low vs medium adherence to Mediterranean diet was associated with a 13% higher risk for all-cause mortality (hazard ratio [HR] 1.13; 95% CI 1.01-1.26). The risk for overall mortality reduced by 8% (HR 0.92; 95% CI 0.87-0.97) for every 3-unit increase in the adapted relative Mediterranean diet score, with the association sustaining in case of postmenopausal women only.
Study details: Findings are from an analysis including 13,270 women with incident BC from a prospective, multicenter European cohort of 318,686 women.
Disclosures: This study was funded by the AECC Scientific Foundation. The authors declared no conflicts of interest.
Source: Castro-Espin C et al. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: Results from the EPIC cohort study. BMC Med. 2023;21:225 (Jun 26). Doi: 10.1186/s12916-023-02934-3
Key clinical point: Adherence to a Mediterranean diet before being diagnosed with breast cancer (BC) may improve survival outcomes, particularly in postmenopausal women.
Major finding: A low vs medium adherence to Mediterranean diet was associated with a 13% higher risk for all-cause mortality (hazard ratio [HR] 1.13; 95% CI 1.01-1.26). The risk for overall mortality reduced by 8% (HR 0.92; 95% CI 0.87-0.97) for every 3-unit increase in the adapted relative Mediterranean diet score, with the association sustaining in case of postmenopausal women only.
Study details: Findings are from an analysis including 13,270 women with incident BC from a prospective, multicenter European cohort of 318,686 women.
Disclosures: This study was funded by the AECC Scientific Foundation. The authors declared no conflicts of interest.
Source: Castro-Espin C et al. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: Results from the EPIC cohort study. BMC Med. 2023;21:225 (Jun 26). Doi: 10.1186/s12916-023-02934-3
Key clinical point: Adherence to a Mediterranean diet before being diagnosed with breast cancer (BC) may improve survival outcomes, particularly in postmenopausal women.
Major finding: A low vs medium adherence to Mediterranean diet was associated with a 13% higher risk for all-cause mortality (hazard ratio [HR] 1.13; 95% CI 1.01-1.26). The risk for overall mortality reduced by 8% (HR 0.92; 95% CI 0.87-0.97) for every 3-unit increase in the adapted relative Mediterranean diet score, with the association sustaining in case of postmenopausal women only.
Study details: Findings are from an analysis including 13,270 women with incident BC from a prospective, multicenter European cohort of 318,686 women.
Disclosures: This study was funded by the AECC Scientific Foundation. The authors declared no conflicts of interest.
Source: Castro-Espin C et al. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: Results from the EPIC cohort study. BMC Med. 2023;21:225 (Jun 26). Doi: 10.1186/s12916-023-02934-3